| INTRODUCTION:
Tremendous technological advances in cardiac surgery have
allowed a significant decrease in the morbidity and mortality once
common in neonates and in young infants with congenital heart
disease. With many centers now experiencing excellent immediate
surgical results, should we not concentrate on improving the
long-term outcomes utilizing novel surgical approaches?
Perhaps a surprise to some, congenital heart disease remains
common, affecting nearly one percent of all newborns. It has
been estimated thatapproximately 32,000 children will be born
in this country with heart defects,a large proportion of these
requiring intervention. Currently, more than half of the children
undergoing cardiopulmonary bypass (CPB) in North America
are younger than 1 year of age.
For the neonate, infant or child undergoing cardiac surgery,
smaller incisions mean less tissue disruption and discomfort,
faster recovery and better cosmetic results. In addition, our data
would support a lower incidence of significnat infections in all
ages using these newer techniques. For the surgeon, however,
this smaller workspace presents several challenges: decreased
vision, less room for hands and instruments to work, and no
room for an assistant's hand. In addition, many of the currently
used instruments are simply too large to work within the confined
space. Despite these current limitations in equipment and the
increased demands it places on the surgeon, minimally invasive
cardiac surgery is rapidly becoming the future of cardiovascular
surgery. The external pressures for change remain diverse and
strong, and thus procedures such as ours, that potentially reduce
hospital resources while maintaining cosmetics and patient safety
will be supported on multiple levels. Parents for example,
remain ecstatic that their children can undergo complex open-heart
procedures safely while staying only 1-3 days in hospital. A well
placed 2-inch incision is all that remains of their brief hospitalization.
There are some that remain skeptical of change, stating that
minimally invasive techniques of surgery are no more than
a publicity stunt without scientific merit. Legitimate concerns
over children's safety, the length of the procedure
including the cardiopulmonary bypass and x-clamp times),
and the duration of hospitalization has been
addressed in our initial and/or intermediate experience
demonstrating no untoward mortality or significant morbidity.
Initial experience with the correction of simple defects has
enabled the repair of more complicated defects utilizing the
mini-sternotomy. Working with a Californian company,
our first generation robot has modified to correct both simple
and complex types of congenital heart defects through
incisions no larger than 2 inches. Original developments
and designs (a virtual port avoiding thoracoscopic ports)
have enable improved robotic function via the mini sternotomy
reducing the multitude of potentially disfiguring thoracic
ports regardless of age and body stature and thus
should standardize the procedures allowing widespread
acceptance into the medical community.
That is, all patients should benefit!
It is important to note: that the innovative techniques
described above, can now be successfully used
in the repair of adults with congenital heart disease.
Adults too can have the BENEFITS of a
MINIMALLY INVASIVE surgical repair - a
cosmetic repair, early extubation and discharge.
For the mother who asked about subaortic fibromuscular obstruction (August. 03),
here is a brief video of a minimally invasive surgical resection.
Below is a young boy staus post extra-cardiac Fontan
operation who just gave me this great photo.

|